መነሻ › የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ
በአሜሪካ ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ ተሳታፊዎችን እየፈለጉ ያሉ ክሊኒካዊ ጥናቶች
ለየራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ የሚደረጉ 178 ጥናቶች በአሜሪካ ውስጥ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በጣም ብዙ ጥናቶች ያሏቸው ከተሞች
- Houston, TX47 ጥናቶች
- Los Angeles, CA42 ጥናቶች
- Boston, MA40 ጥናቶች
- Nashville, TN39 ጥናቶች
- New York City, NY39 ጥናቶች
- St. Louis, MO28 ጥናቶች
- Arlington, VA26 ጥናቶች
- Philadelphia, PA26 ጥናቶች
- Chicago, IL26 ጥናቶች
- Atlanta, GA24 ጥናቶች
- Pittsburgh, PA22 ጥናቶች
- New Haven, CT22 ጥናቶች
- San Antonio, TX22 ጥናቶች
- Dallas, TX20 ጥናቶች
- Queens, NY20 ጥናቶች
- Columbus, OH20 ጥናቶች
- Portland, OR19 ጥናቶች
- Cleveland, OH18 ጥናቶች
- Durham, NC17 ጥናቶች
- Orlando, FL16 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Detroit, MI15 ጥናቶች
- Baltimore, MD15 ጥናቶች
- Tampa, FL15 ጥናቶች
- Edison, NJ15 ጥናቶች
- Grand Rapids, MI15 ጥናቶች
- Cincinnati, OH14 ጥናቶች
- Miami, FL14 ጥናቶች
- San Diego, CA14 ጥናቶች
- Charleston, SC14 ጥናቶች
- Santa Monica, CA13 ጥናቶች
- Milwaukee, WI13 ጥናቶች
- Omaha, NE13 ጥናቶች
- Oklahoma City, OK13 ጥናቶች
- Rochester, MN12 ጥናቶች
- Jacksonville, FL12 ጥናቶች
- Richmond, VA12 ጥናቶች
- Cedar Rapids, IA12 ጥናቶች
- Ann Arbor, MI12 ጥናቶች
- West Valley City, UT11 ጥናቶች
በክልል
- New Jersey26 ጥናቶች
- New Mexico3 ጥናቶች
- New York54 ጥናቶች
- North Carolina27 ጥናቶች
- North Dakota6 ጥናቶች
- Ohio46 ጥናቶች
- Oklahoma14 ጥናቶች
- Oregon19 ጥናቶች
- Pennsylvania41 ጥናቶች
- Rhode Island7 ጥናቶች
- South Carolina21 ጥናቶች
- South Dakota9 ጥናቶች
- Tennessee43 ጥናቶች
- Texas69 ጥናቶች
- Utah21 ጥናቶች
- Vermont3 ጥናቶች
- Virginia42 ጥናቶች
- Washington18 ጥናቶች
- Wisconsin15 ጥናቶች
- ሉዊዚያና6 ጥናቶች
- ሚሺጋን36 ጥናቶች
- ሚኔሶታ23 ጥናቶች
- ሚዙሪ29 ጥናቶች
- ማሳቹሴትስ42 ጥናቶች
- ሜሪላንድ18 ጥናቶች
- ሞንታና5 ጥናቶች
- ኒብራስካ15 ጥናቶች
- ኒው ሃምፕሻየር3 ጥናቶች
- ኔቫዳ4 ጥናቶች
- አላባማ7 ጥናቶች
- አሪዞና18 ጥናቶች
- አርካንሳስ11 ጥናቶች
- አይዳሆ4 ጥናቶች
- አዮዋ14 ጥናቶች
- ኢሊኖይ30 ጥናቶች
- ኢንዲያና13 ጥናቶች
- ከንታኪ16 ጥናቶች
- ካሊፎርኒያ72 ጥናቶች
- ካንሳስ9 ጥናቶች
- ኮሎራዶ23 ጥናቶች
- ኮነቲከት24 ጥናቶች
- ዲስትሪክት ኦፍ ኮሎምቢያ9 ጥናቶች
- ዴላዌር3 ጥናቶች
- ጆርጂያ26 ጥናቶች
- ፍሎሪዳ53 ጥናቶች
በቅርብ ጊዜ የተዘመኑ ጥናቶች
Official study text (English)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06788990A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07189871A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07090499Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07085091A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT07814248A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07744126Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07360314A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05877599A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07219212BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05136196A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07276399JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04892173Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06980038A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06385080A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06047379Intratumoral N17350 in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07339176Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04671667Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05983432Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06736379ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።